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Abstract 
There are many risks and concerns accompanied with the benefits of big data in genomics 
science. In a recent poll conducted by the Huntington Post and YouGov organization on the 
DNA breakthroughs, the majority of Americans (38%) is excited about the main scientific 
breakthroughs on human, plant and animal DNA (YouGov, 2014). However, many of them are 
concerned about the privacy and ethics of genetic research. 34% of the surveyors strongly 
disapproved of scientists using DNA and cloning technology to bring woolly mammoths and 
other extinct species back to life (YouGov, 2014). 52% strongly disapproved of scientists using 
research on human DNA to produce children with unusually high intelligence or other special 
attributes (YouGov, 2014). Lastly, 35-37% of American surveyors are very worried about that 
scientists may begin to 'play God' (YouGov, 2014). What can these statistics tell us? Apparently, 
they point out to us that there is a clear distrust between the public and the experts (the scientists). 
Also, there is a high level of risk perception on genetic/genomic technology among the public. 
Bioscientists, social scientists, policymakers and other experts in the field are working hard to 
bringing genomics technology from the lab setting into the real healthcare system; however, they 
seem to miss or ignore the public's desires and opinions in this issue. Therefore, this paper will  
review the genomics literature and the impacts of genetic testing among the public, and conduct 
a survey among Simon Fraser University students as a sample representing the populations of 
British Columbia to explore the public perceptions on multiple themes of the knowledge and 
attitude of the public towards genetic testing and government legislation regulating; the impact 
of genetic technologies on women; the health system implications; the privacy concerns over 
genetic information including access, control and trust; and the ethical implications of genetic 
testing 
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This is the century of genomics. From the human embryo to the food we eat every day, they can 
all be modified by genetic technology. In fact, DNA technology is blossoming and changing the 
world today. In 2003, the success of Human Genome Project (HGP) allowed scientists to 
sequence the whole human genome. This achievement has led to many promising breakthroughs 
in science and medicine. Through whole genome sequencing, researchers can tailor treatments 
and produce personalized medicine for diseases such as cancer, Huntington's diseases and so on. 
Also, with the advancement of DNA technology, the cost of sequencing the human genome has 
been dropping sharply. Today, for $99, we can easily purchase a genetic test through 23andMe, a 
well-known American direct-to-consumer genetic testing service. All of these medical 
achievements are contributed with the help of big data. Big data enables the collection and 
storage of hundreds of petabytes of human genomic data, which allows our human genome to be 
sequenced faster and cheaper (Vanacek, 2012). Therefore, this is also the era of big data. 
 In 1994, Time magazine's cover featured a story entitled "Genetics: The Future is Now"  
(Caulfield, 2012, p. 100). A decade later, Time again ran another cover on genetics to tell us that 
"gene science has changed our lives" (Caulfield, 2012, p. 100). Then, two decades later, in 2013, 
Time featured a story called the "Angelina Effect"; it depicts the major breakthroughs of genetic 
technologies in the diagnostics for high risk genes and the celebrity impact on public perceptions 
of biotechnology. In a very recent study conducted by PewResearch, most Americans (59 
percent) are very optimistic about the positive impacts of technology and science on society 
(Smith, 2014). At the same time, 30 percent of Americans think these changes in science and 
technology will lead to a worse future for human beings (Smith, 2014). In fact, science is a 
double-edge knife. In the case of genetic technologies, there are benefits and challenges. The 
goal of my paper is to explore public perceptions of genetic testing in British Colombia. This 
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includes the knowledge and attitude of the public towards genetic testing; the impact of genetic 
technologies on women; the health system implications; the privacy concerns over genetic 
information including access, control and trust; and the ethical implications of using genetic 
informationto contribute to the policymaking process of bringing genomics technology from the 
lab setting into the healthcare system.  
The century of biotechnology 
Today, the cost of whole genome sequencing has dropped to thousands of dollars, and soon it 
will be a few hundred, the equivalent of a flight ticket from Vancouver to San Francisco. The 
genetic testing market is blossoming more than ever with the boom of biotechnology stocks in 
the past two years (Herper, 2014). The biotech boom has been fueled mostly by innovations in 
therapeutics, the creation of new lucrative drugs and the research breakthroughs in life sciences 
(Herper, 2014). With the decreasing cost of genetic testing and the development of 
biotechnologies, the public now has easier access to the structure of their genes and detecting the 
the risk their genetic diseases. However, does the public fully understand what genetics is? That 
is one of the questions that this paper is trying to answer.  
 Genes are the units of heredity. This was first illuminated in the 1860s by Gregor Mendel, 
who tried to understand what causes the traits in pea plants, such as wrinkly pea skin, passing 
from one generation to another (Caulfield, 2012, p. 103). It was not until 1953 that the structure 
of the unit of heredity for Deoxyribose Nucleic Acid (DNA) was published in a one-page article 
in the journal Nature by American biologist James Watson and English physicist Francis Crick 
(Caulfield, 2012, p. 103). The discovery by Watson and Crick led to a variety of new 
technologies that allowed scientists to read the biological code of human DNA (Caulfield, 2012, 
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p. 103). This ability to analyze human DNA brought higher ambitions in bioscience to sequence 
the whole human genome. The sequence of human genome is the study of a 3-billion base pair 
consensus sequence of the euchromatic portion generated by the whole-genome shotgun 
sequencing method (Venter, 2001, p. 1305). By decoding our human genome, we can understand 
the differences in DNA mutations resulting in complex diseases (Chow-White, 2008, p. 1175).  
 The two well-known projects that study the human genome are: The Human Genome 
Project (HGP) and the Human Haplotype Map (HapMap). In 1990, the HGP was launched in the 
United States with the funding of three billion dollars. It took nearly a decade and a whole team 
of experts around the world to finish it in 2003. In 2003, 99 percent of gene-containing part of 
human DNA sequence was sequenced with 99.99 percent accuracy (Caulfield, 2012, p. 104). The 
significance of this project is immeasurable. As stated by the director of the National Institutes of 
Health, the goal of the HGP is to improve human health and reduce the burden of disease for all 
people (Caulfield, 2012, p. 104). The second project applies a different method to study our 
DNA. The HapMap project studies our genomes at different population groups of European 
descent, the Yoruba population of African origin, Han Chinese group from Beijing, and Japanese 
people from Tokyo (Bush and Moore, 2012). The purpose of the HapMap project is to 
understand the variation in genomics across different ethnic groups to personalize medicine and 
treatments for diseases in according to our race (Bush and Moore, 2012).  
 In 2003, the Human Genome Project, funded by the government, cost $2.7 billion to 
sequence a human genome (Lohr, 2013). Today, the whole genome sequencing only costs $3000 
(Lohr, 2013). It is predicted that in the next three years, that $3000 testing cost will go down to 
only $100 (Lohr, 2013). In fact, 23andMe, a Californian-based DNA testing service, offers a $99 
package for DNA testing to find out our personal genetic information (Murphy, 2013). It is just 
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amazing how the cost of those scientific testing can plummet in such a short period of time and 
become openly accessible for the public. That is why most Americans are very excited about 
breakthroughs in science and technology; however, we should be more critical in measuring the 
success of the HGP and the use of genetic testing: "To what extent did the scientific and medical 
advances derived from the HGP reduce the burden of disease for all people?" (Caulfield, 2012, p. 
104). Trying to answer this question requires us to understand the significant factor behind the 
success of the HGP that promises to change everything and to cure all our diseases. That factor is 
big data.  
The era of big data 
Big data is the giant tool that controls how we live, work and think (Mayer-Schonberger & 
Cukier, 2013). At this moment, big data might be a new concept for a majority of people; 
however, it is constantly reshaping all aspects of our lives. In 2009 when the virus H1N1 actively 
struck, while the old-school government official statistics failed to report the virus trend, 
Google’s system successfully predicted and identified the spread of the flu (Mayer-Schonberger 
& Cukier, 2013, p. 2). The success of Google’s system in indicating the massive flu trend was 
built on the technique of “big data”.  Big data is defined as "the ability of society to harness 
information in novel ways to produce useful insights or goods and services of significant value" 
(Mayer-Schonberger & Cukier, 2013, p. 2). For big data, knowing "what" is enough; the "why" 
is unnecessary to explore and "the more and the messier the data are, the better the measurement 
is" (Mayer-Schonberger & Cukier, 2013, p. 7). Approximation is good enough, accuracy or 
precision is not required (Mayer-Schonberger & Cukier, 2013). The core of big data is prediction 
and its principle is N=all (Mayer-Schonberger & Cukier, 2013). By gathering a tremendous 
amount of data, big data allows us to identify trends and patterns in all areas of life.  We are 
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living era exploding with data. In contrast to Medieval Europe when a stock of information took 
fifty years to double after the invention of printing, information and data are exponentially 
growing every second. Google processes 24 petabytes of data everyday; that amount exceeds 
thousands of times the quantity of printed materials in the U.S. Library of Congress (Mayer-
Schonberger & Cukier, 2013, p. 8). Facebook, which is just less than 10 years old, stores 10 
millions new photos uploaded by its users every hour (Mayer-Schonberger & Cukier, 2013, p. 8). 
Everyday, Twitter exceeds 400 million tweets per day in 2012 (Mayer-Schonberger & Cukier, 
2013, p. 8). Thus, in 2013, the amount of stored information around the world is estimated 
approximately 1,200 exabytes of which more than 98 percent is digital and less than 2 percent is 
printed (Mayer-Schonberger & Cukier, 2013, p. 9).  
 In health settings, big data plays a significant role in sharing and storing massive amounts 
of data about human genomic traits. HGP is an international collaborative project between many 
expert teams around the world, including the Department of Energy (DOE) and the National 
Institutes of Health (NIH) in the U.S. as well as the Wellcome Trust at the Sanger Center in 
Cambridge, England along with other international partners (Collins, 1999). It took sixteen years 
to upload the first billion bases into the data base; today, with the help of big data, it only took 
fifteen months to add the second billion bases into a computer data sharing system called 
GeneBank (Collins, 1999). GeneBank stores over 39,000 species and receives over 200,000 
queries a day for information on gene sequences and over 60,000 sequence-comparison searches 
every single day (Collins, 1999, p. 29). For research purposes, all this data is available to the 
public domain so that any scientist, whether based at a university, a corporation, or a government 
lab, can have access to the sequence data (Collins, 1999, p. 29). For Collins (1999), this is a 
significant advancement in data-sharing for a public-private partnership of genomics research (p. 
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33). All the genome data is gathered in the cloud, from within a massive universe of information; 
and through algorithmic queries, scientists seek for patterns and similarities that reveal general 
insights about whole populations (Miller, 2014). That is how big data works. At the same time, 
big data can also generate some misperceptions and mischaracterizations about human 
conditions as well as  become a massive form of surveillance on the societal population.  
 Collins (1999) also clearly stated the four characteristics of the HGP, which are: accurate, 
assembled, affordable and accessible (p. 29). First, the sequence must be accurate. Secondly, 
from the short lengths of sequenced DNA, scientists can assemble longer, genomic-scale pieces 
that reflect the original genomic DNA (Collins, 1999, p. 29). Third and fourth, the new whole 
genome sequencing technology must also be affordable and accessible to the public (Collins, 
1999, p. 29). It seems like the HGP actually fulfilled all those promises. The most outstanding 
example of the affordable and accessible application of the HGP is the DNA testing kit from 
23andMe. For $99 a kit, 23andMe can provide us detailed ancestry information, responsiveness 
to 25 drug therapies, and the probabilities of having complex diseases embedded in our genes 
such as BRCA1 mutation which could cause breast cancer in women (Miller, 2014, p. 1). The 
goal of 23andMe is to revolutionize the healthcare industry by giving the public easy access to 
their genetic information. A more ambitious goal of 23andMe is to create "the world’s largest 
secure, private database of genotypic and phenotypic information that can be used for 
comparison analysis and research” (Miller, 2014, p. 3). By fall 2013, 23andMe had analyzed the 
DNA of 650,000 people, making it the one of the biggest biobanks in the world (Miller, 2014, 
p.1). 23andMe is well known for their generous funding and collaboration with Michael J. Fox 
Foundations in the research of finding the cure for Parkinson's disease. However, the dangerous 
thing about 23andMe constructing their own private biobank is that by providing any sample to 
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the company, we automatically give them our consents to use our genomic information in any 
research or commercial products. As a result, we give up the rights to our fundamental privacy 
and control of our own genetic information. Are we fully aware of all the risks of genetic testing? 
Trying to answer this question requires us a good understanding about the public perceptions of 
genetic technologies. The most popular source for the public to seek information about genetic 
and medical advances is from the media; and thus, it is worthwhile to examine the relationship 
between biotechnology and the popular media. 
Genohype: the selling of science 
Genohype is a phenomenon in which the media portrays science, in general, and genetics, in 
particular, inaccurately and unrealistically. Technically speaking, the term 'media' includes all 
forms of popular media from newspapers, movies, television news and social media. For 
example, within the movie industry, there are innumerous movies portraying superheroes or 
superpower with special genes in this past decade. The Canadian actress, Rachel McAdams, is a 
perfect example. In less than five years, she starred in two movies, which are The Time 
Traveler's Wife (2009) and About Time (2013), playing the wife of a man who has the time travel 
superpower in his genes, which led to the separation of the married couple.  In addition to the 
fictional portraits of genetics in movies, our genes have also become a source to blame for all the 
social issues: "Is 'Laziness Gene' to Blame for Couch Potatoes?";  "The Good Gene: Does Our 
DNA Compel US to Seek a High Power?"; "Always Lost?: It May Be in Your Genes"; "Party 
Animal: It May Be in Your Genes"; "Marriage Problems? Husband's Genes May Be the 
Problem"; and "Genes May Affect Popularity, Researchers Say" (Caulfield, 2012, p. 100). With 
these shocking headlines, the media aims to individualize our social issues as own our problems 
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embedded in our genes and to shift away our collective responsibilities as a society, and broader 
sociopolitical factors causing the problems.  
 However, we might be surprised to know certain studies actually show that the media 
representation of science is accurate. In a survey of first authors from the scientific community 
who had interactions with the media, 86 percent of the respondents rated the scientific studies 
coverage as "accurate" (Caulfield, 2004, p. 337). In addition, among 207 news stories on drugs 
for disease prevention, most of them show both sides, the benefits and the harms, of the drugs; 
only 15 percent presented both relative and absolute benefits (Moynihan et al., 2000). As a result, 
we should not completely blame the media for the inaccurate claims about science. There are 
always reasons for everything; and the selling of science in the media also has its purposes. 
Under the increasing pressure to attract more grants or funding, researchers and research 
institutions tend to expose themselves to the media with the emphasis on the near-future benefits 
of their findings (Caulfield, 2004, p. 338). Therefore, university research gradually is becoming 
an important part of the economic agenda and their research is also turning into a commercially 
driven research environment associated with potentially commercial products (Caulfield, 2004, p. 
338). As a result, our three parties: researchers, research institutions and the media all can share 
short-term benefits as 'complicit collaborators' in the business of selling scientific discoveries.  
 In some circumstances, academic scientists and researchers are reluctant to collaborate 
with reporters to sell their credibility. In a study on trust and public perceptions of biotechnology 
research, university scientists are ranked with high credibility and mostly trusted by 53 percent 
of Canadians (Caulfield & McGuire, 2012). The more trusting the public are with researchers, 
the easier for them to buy into the media stories portraying scientific research. Overly optimism 
or unrealistic view about genetic discoveries can negatively impact public understanding of 
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biotechnology. For example, in one study about patients' attitudes about autonomy and 
confidentiality in genetic testing for breast-ovarian cancer susceptibility, researchers found out 
that 95 percent of women with first-degree relatives of women with breast cancer strongly felt 
the need to get their genes tested in spite of their physician's recommendation to the contrary 
(Caulfield, 2004, p. 338). On May 14, 2013, American actress and director Angelina Jolie shared 
with the world through her personal letter to the New York Times that she had gone through a 
double mastectomy to prevent her high risk of having breast cancer and ovarian cancer (Jolie, 
2013). In the letter, Jolie was hoping to raise awareness for women, who may be living under the 
shadow of having cancer, to take action and get their gene tested (Jolie, 2013). Jolie's story has 
inspired as well as raised awareness for many people about the effectiveness and accuracy of life 
sciences technology and promoted the business of genetic testing or whole genome sequencing 
for health risk preventions. That is why Time Magazine called it the Angelina Effect.  
 The power of the Angelina effect can be demonstrated by its popular trend on the social 
media. The New York Times Twitter post on her story was retweeted almost 5000 times and 
received almost 2000 comments and a Google search of online news postings yielded more than 
2000 results (Hurley, 2013). This data indicates that celebrities have an impact on promoting 
public health issues. Yet, in a current study on the Angelina effect, the researchers concluded that 
while three out of four Americans knew about Angelina Jolie's double mastectomy, less than 10 
percent of respondents understood fully about the BRCA gene mutation or genomics testing 
(Borzekowski, 2013). Therefore, celebrities only have the power to raise awareness but not to 
improve scientific public understanding in health-related issues. A recent study shows that of 
more than 8000 patients, about 2500 ended up having a procedure to remove their breast. 
However, the study found that in 49 percent of such cases, the mastectomy was either needless or 
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was being carried out because of a failed previous operation (Donnelly, 2014). Therefore, there 
is an obvious evidence that the public does not have good understanding about genetic testing 
nor sufficient guidance from the healthcare system to make the right decisions with their genetic 
results. In the next section, we are going to examine genetic literacy in academic setting.  
Literature review: an increasing trend in research on genomic technologies 
In contrast with the plummeting of the cost for whole genome sequencing, the literature trend in 
genetics has been rocketing in the past few years. By using PubMed miner, a database storing 
electronically available publications of biomedical and molecular biology literature, we collected 
data about different topics on genomics technologies from National Human Genome Research 
Institute including 'genetic testing', 'medical genomics', and 'genetic discrimination'. These topics 
focus on a diverse range of disciplines from the scientific aspects to the ethical and legal 
implications of genomics technologies .Reflecting from our PubMed mining data, 2012 is a 
golden year for genomic technologies research (see Figure 1). Between 2000 and 2010, there 
were only few studies every year conducted on the topics of 'medical genomics', 'genetic 
discrimination' and 'genetics concerns'. The research started to blossom and reached its peak in 
2012. In 2012, there were more than 1236 articles discussing 'medical genomics', nearly 487 
articles on 'genetic discrimination', 572 articles on 'genetics concerns' such as genomic data 
privacy, and 4208 articles on 'genetic testing'. Apparently, there is an increasing interest in the 
benefits and challenges of genomic technologies. That leads us to a question of why there is this 
trend.  
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Figure 1: Genetics publication trends generated from PubMed  
 It all started with public polls on public opinions about the growing trend of science and 
technology. . In a recent poll conducted by the Huntington Post and YouGov organization on the 
DNA breakthroughs, the majority of Americans (38%) are excited about the main scientific 
breakthroughs on human, plant and animal DNA (YouGov, 2014). However, many of them are 
concerned about the privacy and ethics of genetic research. 34% of the surveyors strongly 
disapproved of scientists using DNA and cloning technology to bring woolly mammoths and 
other extinct species back to life (YouGov, 2014). 52% strongly disapproved of scientists using 
research on human DNA to produce children with unusually high intelligence or other special 
attributes (YouGov, 2014). Lastly, 35-37% of American surveyors are very worried about that 
scientists may begin to 'play God' (YouGov, 2014). This message is brilliantly made into movie 
Transcendence (2014) played by Johnny Depp and Morgan Freeman. The movie builds a battle 
0 
500 
1000 
1500 
2000 
2500 
3000 
3500 
4000 
4500 
1990 1992 1994 1996 1998 2000 2002 2004 2006 2008 2010 2012 
N
u
m
b
e
r 
o
f 
p
u
b
lic
at
io
n
s 
Genetics publications trends  
Genetic testing 
Medical Genomics 
Genetic discrimination  
 
15 PUBLIC PERCEPTIONS OF GENETIC TESTING 
of two contradictory spectrums of ideas between the utopian technology who believes science 
can help cure all our illness and solves all our problems versus the dystopian technology who 
strongly sees science as a threat to the humanity. In a survey conducted on April 2014 by Pew 
Research Center about public views of science and technology, most of U.S. adults are wary of 
some controversial changes that may be on the near-term horizon (Smith, 2014, p. 7). On the 
topic of ubiquitous wearable or implanted computing devices, 53 percent of the respondents 
think it would be a worse future if most people are fed information by devices or implants (Smith, 
2014, p. 7). 65 percent of the respondents also are against robot caregivers for elderly and infants 
(Smith, 2014, p. 7). 63 percent are concerned about U.S. airspace opening to personal drones 
(Smith, 2014, p. 7). Most importantly, 66 percent of the respondents are not in favor of the 
ability for parents to alter DNA of prospective children (Smith, 2014, p. 7). As a result, there are 
huge ethical, social and legal concerns from the public towards the development of science and 
technology. In the case of genetic technologies, many studies and research has been conducted 
on public perceptions of genetic testing in regards to their knowledge, their trust and their ethical 
concerns such as privacy, access and control. 
 In regards to public interests in genetic testing, 70-80 percent of a survey respondents 
indicated their willingness to pay for direct-to-consumer (DTC) genetic testing, 51 percent were 
willing to pay for testing for serious and unpreventable diseases and 64 percent would consider 
using DTC genetic testing to obtain useful health information (Caulfield & McGuire, 2012, p. 
26). In another study, to measure the social networkers' knowledge in genetic testing, the 
researchers asked if the respondents had heard of any personal genome testing companies (PGT); 
and 47 percent of survey respondents reported having heard of personal genetic testing 
companies (McGuire et al., 2009, p. 3). However, only 6 percent of the respondents had used the 
 
16 PUBLIC PERCEPTIONS OF GENETIC TESTING 
services of a PGT (McGuire et al., 2009, p. 3). Yet, 64 would consider using them in the future 
(McGuire et al., 2009). When asked for the reasons to do genetic testing, 81 percent of the 
respondents were curious about their genetic make-up and 74 percent were keen on finding out if 
a specific disease runs in their family or in their DNA (McGuire et al., 2009, p. 4). McGuire et al. 
(2009) also found out the perceived benefits of genetic testing. By getting their genes tested, 53 
percent of the respondents would increase individual's control over their health; 58 percent 
would stimulate discussion about personal health within the family; 65 percent would take into 
consideration their genetic test results for their future health care decisions and 84 percent would 
consult a physician or modify their lifestyle by dieting and exercising more (p. 4).  
 On the other hand, researchers are also interested in the risk perceptions of genetic testing. 
Surprisingly, 42 percent of the respondents were confident in their understanding of all the risks 
and benefits of the PGT (McGuire et al., 2009, p. 4). In term of privacy concerns, a study 
recorded that 37 percent of respondents were afraid that results from a study would be used 
against them; 85.7 percent preferred that their samples were de-linked to their personal 
information; and 26 percent had concerns about the future uses of data from their results (Rachul 
et al., 2012, p. 7). For the access to genetic information, the same study noted that 75 percent of 
the respondents had concerns about governments having their samples and information (Rachul 
et al., 2012, p. 8). Nevertheless, the public seemed to have very much respect and trust for 
researchers since 77 percent of the respondents had a lot of trust in the researchers' ability to 
protect their information (Rachul et al., 2012, p. 8). On a similar topic of trust, Rachul et al. 
(2012) looked at the public perceptions of ownership and control of genetic information. There 
was a large sense that participants own their own samples (Rachul et al., 2012). More than that, 
97 percent of the respondents were more comfortable with a university or hospital managing and 
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storing their samples as opposed to 6 percent were comfortable with for-profit organizations 
managing their samples (Rachul et al., 2012, p. 11). In another study, Caulfield (2006) found out 
that 53% Canadians trusted university scientists in contrast to 23% Canadians trusted researchers 
funded by industry (p. 1353). 
 With much trust and respect for researchers, the public also have a lot of expectations for 
physicians in helping them to understand the results. 78 percent of the respondents in the online 
survey would ask the physicians to interpret the results because physicians have both a 
professional obligation to help individual understand the results and enough knowledge to 
interpret the results for them (McGuire et al., 2009, p. 4). Therefore, the public take for granted 
that doctors and physicians are reliable and knowledgable in managing and interpreting their 
genetic results. In fact, 60 percent of the respondents considered their results as a medical 
diagnosis (McGuire et al., 2009, p. 4). Without physicians' help, genetic results could cause 
anxiety to individuals who get their genes tested. In a systematic review on psychological impact 
of testing, genetic test results could lead individuals to inappropriate behavioral response because 
they could overinterpret the significance of a positive result or gain a false sense of insecurity 
from a negative result (Caulfield & McGuire, 2012). Nevertheless, there are still doubts for the 
genetic test result. 53 percent of the online survey respondents did not think the information 
would be useful; 21 percent had doubts about the reliability of the result (McGuire et al., 2009, p. 
4). Most importantly, 39 percent of the respondents had concerns about the privacy of their result 
(McGuire et al., 2009, p. 4). As a result, in the same study, 51 percents of the survey respondents 
would support federal regulations of PGT companies (McGuire et al., 2009, p. 4). In another 
study,  90 percent of the respondents would support a law to protect genetic data (Rachul et al., 
2012). In a 2001 survey, Canadians expressed their privacy concerns over the genetic 
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discrimination. 61 percent and 29 percent of the survey respondents strongly agreed and agreed 
respectively that genetic information should be governed in a stricter manner than that of other 
forms of personal information (Caulfield & McGuire, 2012, p. 29). Our concerns over our 
genetic information are reasonable since it is our fundamental privacy right that constructs 
biologically who we are. In the next section, I am going to discuss the current legislation in 
Canada in protecting genetic information.  
The inadequacy of Canadian legislation in the protection of genetic discrimination 
While many Western countries such as the United Kingdom and the United States has passed 
laws prohibiting discrimination on the basic of genetic information, Canada is still lagging 
behind. It is argued that the main reason for the lack of protection of genetic discrimination in 
Canada is because Canada has a universal health care system, rather than health insurance. 
Almost every Canadian is on Medical Service Provider, Canadian government does not feel the 
need to impose laws or policies to regulate the private health insurance industry. However, 
Canadians also are very much concerned about genetic discrimination as Americans are. In a 
2006 survey, 39.9 percent of Canadians who were at risk for Huntington's disease had 
experienced discrimination, 29.2 percent of respondents got rejected for their applications for 
insurance coverage and 7 percent reported employment discrimination (Watton, 2009). In a 2003 
survey, 91 percent of Canadians opposed to the access of their genetic information from an 
insurance company or from their employers (Watton, 2009). Therefore, Canadian legislation 
should impose laws or policies to meet the desire of Canadians to be protected against genetic 
discrimination.  
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 At this moment, Canadian law system has several ways of protecting genetic 
discrimination indirectly. First of all, we have the Grounds of Protection under the B.C. Human 
Rights Code. Our genetic information can be applied into the grounds of either ancestry, colour, 
place of origin and race or disability - physical or mental. For the first ground, our genetic 
information is somehow similar to the idea of ancestry and race. 
 Ancestry typically refers to discrimination based on one’s ancestors and is often cited as a 
 ground by First Nations people. Colour refers to skin-tone and extends protection across  the full 
 range of different skin-tones. (Human Rights Code, RSBC 1996, c. 210.) 
 Indeed, our genetic information can be traced back from our ancestry, which constructs 
our skin-tone. Therefore, if a mutation, which can cause cancer, runs in the family gene, and we 
get rejected from health coverage or from a job because of the mutation; that should be 
considered a discrimination based on our ancestry or our race. Also, if an employer refuses to 
hire or promote a person with the risk of having a Huntington's disease for example, it also can 
be considered a discrimination on the ground of disability.  
 All major diseases and illnesses are included in the definition, such as cancer, Alzheimer’s, 
 Crohn’s disease, cerebral palsy, epilepsy/seizures, heart attack, heart conditions, HIV / AIDS, 
 arthritis, etc. All mental illnesses are included in the definition as are conditions associated with 
 developmental delay and learning disabilities. (Human Rights Code, RSBC 1996, c. 210.) 
 Above are the list of diseases and illnesses that are considered disability. However, the 
current legislation still does not address the concepts of future disability, perceived disability or 
imputed disability (Watton, 2009). Nor does it prevent the discrimination to be taken place at the 
first place; it only can offers remedies for damages that the discrimination has caused. As a result, 
the Grounds of Protection is not adequate in protecting genetic information. Furthermore, in 
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employment, under the anti-discriminatory model, genetic discrimination is not necessarily 
prohibited (Thable, 2006, p. 25). Under Canadian labour law, an employer may refuse to hire or 
terminate an employee who do not meet a bona fide occupational requirement (BFOR) (Thable, 
2006, p. 25). BFOR is the most common defence to an act of discrimination in employment 
which is also closely tied to the corresponding duty on the employer to accommodate the 
individual or group affected by the discrimination. In one case, B.C. v. B.C.G.S.E.U., the SCC 
decided that the discriminatory standard of the employers was qualified as a BFOR, because the 
employer adopted the standard for a rational purpose connected to the performance of the job in 
an honest and good faith belief. As a result, in Canadian anti-discriminatory model, some forms 
of genetic discrimination in the workplace is permitted.  
 Another legislation regulating our genetic information is the personal information or the 
privacy act. As genetic information considered ancestry, race or disability, it could also be seen 
as our personal information. Under the Personal Information Protection and Electronic 
Documents Act (PIPEDA), personal information is defined as, 
  information about an identifiable individual, but does not include the name, title or 
 business address or telephone number of an employee of an organization. (PIPEDA) 
 PIPEDA only applies to private section and aims to govern the collection, use and 
disclosure of personal information as a protection of the right of privacy of individuals. Under 
section 4 of the PIPEDA, it is prohibited to collect, use or disclose personal information of an 
employee, 
 4. (1) This Part applies to every organization in respect of personal information that 
 (a) the organization collects, uses or discloses in the course of commercial activities; or 
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 (b) is about an employee of the organization and that the organization collects, uses or 
 discloses in connection with the operation of a federal work, undertaking or business. 
 PIPEDA is a great means to protect our personal information against any misuse in 
private sectors. However, there are cases that government bodies or public sectors such as 
university institutions or researchers or government themselves use or access our personal 
information in general without our consent or permission. PIPEDA does not have the jurisdiction 
to protect us from this public group. Therefore, we have another act called Freedom of 
Information and Protection of Privacy Act (FIPPA), which aims to protect personal privacy. Part 
III in the FIPPA clearly states the protection of personal information applied in employment in 
the public sector. 
 30  A public body must protect personal information in its custody or under its control by 
 making reasonable security arrangements against such risks as unauthorized access, 
 collection, use, disclosure or disposal. (FIPPA) 
 31.1  The requirements and restrictions established by this Part also apply to 
 (a) the employees, officers and directors of a public body, and 
 (b) in the case of an employee that is a service provider, all employees and associates of  
 the service provider. (FIPPA) 
 While PIPEDA governs the private sectors in protecting our personal information, FIPPA 
manages the public sectors in protecting our personal privacy. However, that is still not enough 
protected required for our genetic information. In a 2001 survey, Canadians expressed their 
privacy concerns over the genetic discrimination. 61 percent and 29 percent of the survey 
respondents strongly agreed and agreed respectively that genetic information should be governed 
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in a stricter manner than that of other forms of personal information (Caulfield & McGuire, 2012, 
p. 29). In the next section, I am going to present my own study about the public perceptions of 
genetic testing conducted on Simon Fraser University students and staff.  
Method 
The survey was conducted with SFU Websurvey to ensure its security and reliability. For the 
respondents recruitment, we applied random sampling method by distributing the Websurvey 
link to SFU mailing list of all the school departments with the permission of their administrators. 
Also, this study participation is completely voluntary and anonymous; and thus, no personal 
information such as names, addresses, telephone numbers or email addresses of the respondents 
are obtained. The population for this study is adult at consenting age in British Columbia. The 
survey was launched on May 26 and closed on July 23. Its link was sent to different mailing lists 
to SFU departments including Communication, Health Sciences, Criminology, Psychology, 
Political Economy, Public Policy and International Studies and other social media platforms such 
as Facebook and Twitter of SFU Communities. The goal of the survey is to find out the answers 
for these three research questions:  
Q1. How familiar is the public on the topic of genetic testing? 
Q2. How concerned are the public towards their genetic information regarding to privacy, 
access and control?  
Q3. What are the impacts of genetic testing on health care system and on women?  
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Results  
Respondents (Independent variables) 
Respondents (N = 100; males n = 37%; females n = 63%, other n=1%) are students and staff at 
Simon Fraser University from different departments and faculties. For the independent variables 
from the respondents, we are mainly interested in looking at their age, majors, political views 
and ethnicity. In this study, the majority of our respondents are between 21 to 24 (40%) with the 
racial background of White (61%) and majoring or working in the field of Arts and Social 
Sciences (43%) or Communication, Art and Technology (40%). For political views,  11 percent 
of our respondents are Conservative, 35 percent are New Democratic Party and 14 percent are 
Liberal. Another important finding in this study is that our respondents follow news about 
science and medicine not closely at all (17%), not too closely (51%), somewhat closely (26%) 
and very closely (7%).   
Dependent variables 
The main themes of genetic testing of this study are: the knowledge and attitude of the public 
towards genetic testing and government legislation regulating, the impact of genetic technologies 
on women, the health system implications, the privacy concerns over genetic information 
including access, control and trust, and the ethical implications of genetic testing.  
Knowledge 
Five topics related to genetics and biotechnology are used to test the knowledge or the level of 
familiarity of the respondents towards genetic testing: genetic testing, prenatal testing, designer 
babies, biobank and stem cell research. The majority of our respondents only know something, 
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not much about genetic testing (71%), prenatal screening (66%), designer babies (47%), biobank 
(39%) and about stem cell research (72%). There is just a small portion of the respondents who 
know a great deal about genetic testing (21%), prenatal screening (18%), designer babies (9%), 
biobank (7%) and stem cell research (11%).  
 The survey also examines the knowledge of the respondents about government 
legislations of genetic testing and genetic technologies. 66 percent of our respondents do not 
know if the government regulates genetic testing. The other 20 percent of the respondents think 
that the government regulates genetic testing while 15 percent do not think so. We see the similar 
trend for genetic technologies. 64 percent of our respondents are unsure if the government 
regulates genetic technologies. While 22 percent reckons that the government does regulate 
genetic technologies, 15 percent reckons the opposite thing.  
Impact of genetic technologies on women 
The survey tackles on topics related to the use of genetic technologies on women including the 
diagnosis of BRAC 1/2, the possibility of double mastectomy and in vitro fertilization, the 
process of helping women to  become pregnant by biotechnology.  When asked if our 
respondents are aware of the Angelina Jolie event of conducting double mastectomy to remove 
her high risk of having breast cancer occurred May, 2013, 78 percent of our respondents know 
about this event.  A follow-up question to this event are if the genetic test showed that the 
respondents were carrying the BRAC1 or BRAC2 gene which might cause them breast cancer or 
ovarian cancer, would the female respondents conduct (double) mastectomy operation as 
Angeline Jolie did? Also, from a male perspective, would our male respondents support their 
female partners/relatives/friends to conduct the mastectomy? 38 percent of our respondents 
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would conduct or support the mastectomy and 40 percent of the respondents are unsure about 
their decision for this scenario. Also, 22 percent of our respondents oppose the idea of 
conducting the mastectomy. Furthermore, when asked if the respondents have considered or 
know anyone who have considered becoming pregnant by using in vitro fertilization, the 
majority of them (56%) do seem to be familiar with this fertilization technology.  
Health system implications 
One of the most interesting topics this survey is trying to find out is the implications of genetic 
testing on the health system. First, we would like to understand the value of genetic test result to 
our respondents. 39 percent of our respondents consider genetic test result as a medical diagnosis 
(Figure 2). Secondly, we also try to find out how the respondents would understand the genetic 
test result which might be technical. Not surprisingly, 88 percent of our respondents would ask 
the physician to interpret the genetic test results for them. Within this 88 percent, 32 percent of 
them think that physicians have enough knowledge to interpret the results for them, 56 percent of 
them see that physicians have a professional obligation to help individuals understand the results 
(Figure 3).  
 
39% 
39% 
22% 
Genetic test result as medical diagnosis 
Yes  No Don't know 
Figure 2: Respondents' views on whether they consider genetic test result as a medical diagnosis 
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Privacy concerns including access, control and trust  
For this topic, we ask our respondents how much they trust for these categories to access their 
genetic test results: doctor/physician, family members, researchers funded by private sector or 
industry, researchers from public hospitals or universities, law enforcement, health insurer and 
employer (Figure 4). The results reflect that doctor and physician receive the most trust from the 
public (83%) with some and a lot of trust. Family members come second after doctor physician 
with 78 percent of some and a lot of trust from the public. Researchers funded by private sector 
or by industry seem to receive none and just a little trust from the public (74%). On the other 
hand, researchers funded by public hospitals or universities receive a more positive trust than 
those funded by private sector with 57 percent of some and a lot trust, while the latter only 
receives 24 percent of some and a lot of trust from our respondents. The last three categories 
receive negative trust from the public. 79 percent of our respondents do not trust or just at a low 
level of trust for law enforcement. For health insurer and employer, 94 percent and 96 percent 
32% 
55% 
13% 
Should the physician interpret your genetic test 
results for you?  
Yes, because physicians have enough knowledge to interpret the results 
Yes, because physicians have a professional obligation to help individuals understand the results 
No  
Figure 3: Respondents' views on whether the physician should interpret their genetic test results 
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respectively of our respondents have no or low trust for them to access their genetic test results. 
This implies that the public are very cautious of who gets to control their genetic data.  
 
  
 We also examine our respondents the degree of concern about privacy for their genetic 
information and about the use of their genetic information (Figure 5). 83 percent of our 
respondents are concerned and very concerned about the privacy of their genetic information. 86 
39% 
34% 
16% 
6% 
3% 2% 
0% 
Parties receive "a lot 
of "trust 
Doctor/physician 
Family members 
Researchers funded by public sectors 
Researchers funded by private industry 
Law enforcement 
Health insurer 
Employer 
30% 
24% 
19% 
17% 
6% 1% 
3% 
Parties receive "no" 
trust 
Employer 
Health insurer 
Law enforcement 
Researchers funded by private industry 
Researchers funded by public sectors 
Doctor/physician 
Family members 
Figure 4. Respondents' trusts for accessing and controlling their genetic data 
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percent of them strongly disagree and disagree that we should allow researchers to share our 
personal information or personal identity with our genetic samples with the public. As a result, 
58 percent of our respondents agree and strongly agree that laws/policies/rules governing the 
protection of our genetic information should be stricter than for other forms of personal 
information.  
 
Figure 5: Respondents' attitudes towards their genetic information 
Ethical implications of genetic testing 
The Likert scale from one to five, in which one is completely unethical, and 5 is completely 
ethical, are used for the respondents to rate the ethical level of the different uses of genetic 
information (Figure 6). 94 percent of our respondents think that it is completely unethical for 
employers to request genetic profiles from prospective employees before deciding to hire them 
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or not. Likewise, 86 percent of our respondents rate that it is also completely unethical for health 
insurance companies to require genetic information before deciding on the cost of health 
coverage. In addition, the concept of 'open consent', which researchers can use our genetic 
information in their research study without our informed consent, is also completely unethical 
and unethical to 76 percent of our respondents. Also, 75 percent of them are against the idea of 
patent law that is applied to human genetic material, which means we can buy a patent for our 
genetic material.  
 
Figure 6: Respondents' attitudes toward the use of their genetic information 
Interesting Correlations  
Political views on genetic testing 
One of the goals of the survey is to produce both quantitative and qualitative data by using Excel 
to code close-ended questions and applying SPSS to analyze crosstabs between different 
variables. The first cross tabulation is the political perspectives on the role of government in 
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genetic testing. We ask our respondents for their general political views and their thoughts on 
whether the government should regulate genetic testing and/or genetic technologies (Fig. 7). The 
results are quite consistent. Within the biggest parties in Canada, the Conservative party has the 
least support for government regulation of genetic testing (63.6%) or genetic technologies 
(44.1%). To the left spectrum of political views, Liberals are a huge supporter of genetic testing 
(64.3%) and genetic technologies (50%). Likewise, New Democratic Party is the biggest 
supporter for government regulations of genetic testing and genetic technologies (71.4%).  
 
  
 As a result, it is not surprising to find out that these political views also have different 
support for laws/policies/rules governing genetic information to be stricter than that of our 
personal information. 35.7 percent of Liberals respondents agree to the need for a stricter law 
regulating our genetic information. Likewise, 37.1 percent of NDP respondents also agree with 
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Figure 7: Relationship between political views and whether government should regulate genetic testing 
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the statement above. Green Party of Canada is the biggest supporter for Not surprisingly, only 
18.2 percent of Conservatives agree that laws regulating genetic information should be stricter 
than that of our personal information.  
Age and privacy concerns over genetic information  
The second correlation we are interested in matching up is the relationship between age and their 
concerns about the privacy of their genetic information (Fig. 8). In general, all the ages group are 
concerned or strongly concerned about their genetic information, but the age group from 50 and 
above are the most concerned one. 100 percent of our respondents aged from 50 and above are 
concerned or strongly concerned about their genetic information. Interestingly, 85 percent of the 
young people aged from 21-24 are also concerned and very concerned about their genetic 
information. This is a good news because they are the future of our society and their concerns 
will reflect which directions our society is going to grow to protect the privacy of the genetic 
data. 77 percent of respondents aged from 25-29 are also in the same state of mine for their 
genetic information. 80 percent and 75 percent of age group 30-40 and 40-50 respectively are 
also concerned and very concerned about their genetic information. These trends show a high 
awareness of populations at all ages about the privacy issues related to their genetic information.  
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Figure 8. Relationship between age and genetic information privacy concerns  
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Gender views on designer babies 
In addition, we match up our independent variable, gender, with our dependent variable, the 
ethics of designing babies with desirable traits (Fig. 9). In general, 74 percent of our respondents 
are opposed to the use of genetic testing for parents to design their unborn babies with all 
desirable traits such as high intelligence or strength. Astonishingly, female are more against the 
idea of designing babies than male. 76 percent of female respondents oppose/strongly oppose 
'designer babies'. On the other hand, only 62.1 percent of male respondents strongly oppose 
'designer babies'. This reflects that gender affects their attitudes and opinions toward genetic 
technologies and scientific innovations. This is a new worthwhile area for research.  
 
 
53% 
23% 
11% 
11% 
2% 
Female views on designer babies 
Strongly oppose Oppose Neutral Support Strongly support 
35% 
27% 
24% 
8% 
6% 
Male views on designer babies  
Strongly oppose  Oppose Neutral Support Strongly support 
Figure 9. Relationship between gender and designer babies 
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The Angelina effect 
The most important correlation we try to measure is the impact of Angelina Jolie's double 
mastectomy story on the decision of the public to conduct the operation in a hypothesis scenario. 
With this correlation, we ask our respondents whether they are aware of the event which 
Angelina conducted a double mastectomy to eliminate her risk of having breast cancer and 
ovarian cancer (Fig. 9). Also, we asked our respondents a hypothesis that if they were diagnosed 
with the gene mutation BRCA1 or BRCA2, would they undergo the (double) mastectomy? If the 
respondent is a male, would he support his female partner/relative/friend to conduct the 
mastectomy? 77 percent of our respondents were aware of the event and 22 percent did not know 
about the event. Within that 77.5 percent of the respondents who were aware of the event, 42.9 
percent of them would conduct (for female) or support (for male) the mastectomy operation if 
the BRCA 1/2 showed up in their genetic tests. In fact, also a large number of our respondents do 
not know what to do if they were diagnosed with BRAC1/2. 40.3 percent of respondents who 
knew about the Angelina event, were not sure which action to take. The majority of the 
respondents who did not know about the Angelina event, also were not sure whether or not to 
undergo mastectomy (40.9%). As a result, celebrities such as Angelina Jolie can help raise 
awareness about genetic testing and genetic technologies; but her story cannot provide enough 
genetics literacy for the public to fully understand how genetic test results actually work.  
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Discussion and Conclusion 
This study explores the wider sociocultural and political aspects of genomic science in our 
society today. There are many controversies around genomic science such as privacy concerns 
around our genetic information; access, control and trust issues of genetic information; genetic 
discrimination in health care or in employment; and the ethics of genetic technologies in the use 
of designing babies. Bioethics is always a complicated matter, which requires an approach that is 
essentially sociological rather than philosophical (Franklin & Roberts, 2006, p. 3). In the social 
sciences of genomics, we do not tend to work toward identifying the best or definite "answer" to 
a particular question as in natural science or medicine. In contrast, we look at a holistic picture in 
which both questions and answers reveal their specific patterns. The survey sought to find 
specific patterns in public perceptions of genetic testing. Yet, there are no absolute "right" or 
"wrong" values to these patterns. If our genetic information could be used in the study for the 
77% 
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1% 
Were you aware of 
Angeline Jolie event? 
Yes No  Don't know 
43% 
17% 
40% 
Would you conduct a 
(double) mastectomy?  
Yes No  Don't know 
Figure 10: Relationship between respondents' awareness of Angelina event and their attitude toward 
double mastectomy 
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cure of cancer, should we be worried about the privacy of our biological identity and not give out 
our genetic information? Or if genetic technologies such as preimplantation genetic diagnosis 
could be applied to save the life of a child by eliminating a bad gene mutation, should we argue 
that it is unethical to design a baby with a healthy trait? Genomic science is such "a very grey 
area" that its benefits and its risks can actually have the same weight. Despite genetic testing as a 
scientific subject, multiple 'social dimensions' of it need to be addressed by turning to these 4-W 
questions: "Who are the new genetic technologies for? Who benefits from them? Who loses out? 
What are the forms of power and inequality that are channeled through geneticization, genetic 
determinism or the "new genetic essentialism" (Nelkin & Lindee, 1995)" (Franklin & Roberts, 
2006, p. 197)? 
 The results of this survey have shown that the majority of our population recognizes the 
importance of genetic testing and genetic technologies. In addition to that, all age groups of our 
respondents are very concerned about the privacy of their genetic information. Therefore, they 
feel the need for the government to regulate genetic testing and genetic technologies in order to 
protect the ethics and concerns surrounding the use of their genetic information. Most of our 
respondents are interested in getting their genes tested in the future. They also strongly support 
the use of genetic technologies to find new ways to diagnose, prevent or treat diseases such as 
making personalized medicine or early diagnosis of a child with a serious genetic disease. Also, 
a large number of our respondents have some or a lot of trust for their doctor/physician. For 
researchers, the public have a bit of skepticism since a large number of the respondents have no 
trust for researchers funded by private sector or by industry, but some trust for the ones funded 
from public hospitals or universities. This has led to the bulk of our respondents supporting 
government regulation of genetic testing and genetic technologies. We also find that respondents 
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with a more left wing political views like Liberals and New Democratic Party tend to favor more 
government regulations of genetic science. This makes a perfect sense in the context that left-
wing political parties are in favor of more government regulation and intervention in economy, 
social welfare and society as a whole in the contrast with the "invisible hand" approach of the 
right wing political parties. However, the majority of our population do not support genetic law 
to be stricter than other forms of personal information; they are more inclined to stay neutral on 
this topic. Our finding is contrasted with Caulfield's result that 61 percent and 29 percent of their 
survey respondents strongly agreed and agreed respectively that genetic information should be 
governed in a stricter manner than that of other forms of personal information (Caulfield & 
McGuire, 2012, p. 29). In other words, our respondents agree with the need for government to 
regulate genetic science but not in a stricter manner. This might result from the structure of our 
population who are university students, faculties, and staff, otherwise known as, researchers and 
scholars. Whether scientists and researchers support strict regulations on research involving 
human subjects is also a complex issue worth digging into.    
 The next stage of getting your gene tested is to receive and interpret the results. In an 
article written by a genetic testing consumer of 23andMe, Cyrus Farivar (2014) shared with us 
that the complicated thing about the whole process is not to spit our salvia into a tube and mail it 
to California where 23andMe is based for analysis. The tough part is how to understand the 
result. Farivar (2014) stressed that the genetic result he received was technical with no detailed 
analysis and no consultation for the consumer. Even his family physician or local hospital doctor 
could not interpret the diagnosis for him. In fact, in a study of physicians' attitudes about 
multiplex tumor genomic testing, physicians have low genomic confidence and they are not sure 
how to incorporate predictive multiplex somantic genomic tests into practice, and they are 
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uncertain about the disclosure of genomic information (Gray et al., 2013). However, our 
respondents are mainly unaware of these facts. A large number of our respondents consider 
genetic tests as a medical diagnosis, and the majority of them assume that doctors/physicians 
should interpret their genetic test results because either they have enough knowledge to interpret 
the results or they have a professional obligation to help individuals understand the results. 
Genomic science is still a new branch of bioscience; and therefore, most physicians or doctors 
are not fully equipped with expertise about genomic data or information. This situation is quite 
similar to the scenario where physical education teachers have to give sex education in high 
schools while their expertise is completely not about sex-related topics.  As a result, it is 
recommended that direct-to-consumer testing companies should offer consultations for their 
consumers to fully understand their genetic results. This also gives rise to the need for more 
genetic counsellors in order to assist both consumers and physicians in knowing what actions 
they should take with the results, because if we do not really understand the genetic test result, 
we might go down the wrong track.  
 In the case of mastectomy, it is an interesting scenario to examine both the understanding 
and expectation of our respondents towards their genetic test results as well as the Angelina 
Effect and whether Angelina's double mastectomy has a positive impact on its audience. 77 
percent of our respondents could recall the news about Angelina undergoing a double 
mastectomy to prevent her from having breast cancer and ovarian cancer in May 2013. As a 
result, if they were put in the same shoes as Angelina where the gene mutations BRAC1/2 
showed up in their genetic test results,  the majority of our respondents either would conduct the 
mastectomy as Angelina did or they would not know what to do. These two answers both imply 
a problematic hole in the genohype in which the media reports genetics in an inaccurate and 
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unrealistic way. First of all, a genetic test result is far from a medical diagnosis. To examine 
whether you have the BRAC1/2 gene mutation, to know exactly the chance for the mutations to 
develop breast cancer you have to go through a much more complicated and expensive testing 
process which can cost up to $3000. A simple test done at 23andMe cannot tell you for sure if 
you will have breast cancer. On average, women who carry BRAC mutations have about a 65 
percent risk of eventually developing breast cancer; but for most women, the rate of the risk is 
about 12 percent (Grady, 2013). With this misunderstanding in mind, 21 percent of the 
mastectomies were conducted on women whose lumps were small enough that those major 
operations for early breast cancer was needless or unnecessary  (Donelly, 2014). Therefore, when 
a large number of our respondents agree to undergo a mastectomy if their genetic test results 
diagnose them with the BRAC1/2 mutations, that is not a rational decision. On the other hand, 
the majority of our respondents are not sure how to react to the result. That indicates Angelina 
did raise more awareness for the public to know and accept the norm of mastectomy but she 
could not provide enough knowledge and guidance for the public to be fully informed in this 
topic. Angelina Jolie is a wealthy and powerful celebrity; she has a whole team of experts and 
counselors helping her  make decisions. As regular people, we do not have the resources and 
access she has. Therefore, the public needs to have a good understanding about genetic testing 
and sufficient guidance from the healthcare system to make the right decisions with their genetic 
results. 
 Another product, which genomics science can generate, is the application to design 
babies. In the case of ‘designer babies’, it is an unethical act in the eye of many of our 
respondents. 74 percent of them strongly oppose and oppose parents to design their unborn 
babies with all desirable traits such as high intelligence or strength. Female respondents tend to 
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have a bigger aversion towards the idea of designing babies. This might result from the 
representation of the media about the biotechnology as them 'playing God'. Many of the news 
coverage about designer babies carry a dystopian view of technology. Designer babies are 
portrayed to be superhuman, too clever, too fast, and too happy; and that poses a threat to our 
humanity, which terrifies people. ‘Designer babies’ are seen as the product of ‘genetic 
manipulation’ that could alter the fundamental self-understanding of human beings, break down 
the modern conceptions of law and morality, and transform the normative foundations of social 
integration (Franklin & Roberts, 2006, p. 28). This is a problematic thought. First of all, it is 
problematic starting from the word ‘design’. Technically, ‘designer babies’ involves the process 
of embryo selection based on genetic information and morphology and the ability to diagnose the 
presence or absence of a known, single, and specific mutations (Franklin & Roberts, 2006, p. 32). 
As a result, ‘designer babies’ are not only applied to produce superhuman, it can be applied to 
save a human life. In the U.K. in 2002, to save the life of their chronically ill son, Raj and 
Shahana Hasmi decided to design a new baby in order to use his bone marrow. This raised a 
huge ethical and legal debate whether the Hashmis had the right to design a “savior sibling” for 
their older son, in other words, to exploit the newborn child for the sake of the older one. Who 
gets the right to answer yes or no to that debate? What if it happened to your own child and it is 
the only way to cure his illness, what would you choose? Genomic technologies need to be 
regulated but in a flexible and personalized way that everyone who seeks its help can receive the 
right treatment.  
 Out of all the issues discussed above, bioethics is the biggest challenge for genomics 
science. 84 percent of our respondents agree and strongly agree that we should be concerned 
about the privacy of our genetic information. Therefore, our respondents have much skepticism 
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towards the use of their genetic information. 87 percent of them strongly disagree and disagree 
that we should allow researchers to share our personal information or personal identity with our 
genetic samples with the public. More particularly, the use of genetic information in employment 
and insurance received much criticism. 94 percent of our respondents consider it completely 
unethical and unethical for employers to request genetic profiles from prospective employees 
before deciding to hire them or not. 86 percent of them also think it is completely unethical and 
unethical for health insurance companies to require genetic information before deciding on the 
cost of health coverage. As a result, 93 percent of our population strongly oppose and oppose 
employers making decisions about hiring and promotion based on genetic testing results, a 86 
percent also strongly oppose and oppose health insurance companies determining who to insure 
or how much to charge based on genetic testing results. In Canada, currently there are no laws to 
regulate the use of genetic test results by insurance companies. The Canadian Life and Health 
Insurance Association's (CLHIA) Position Statement claims that an insurer would not require an 
applicant for insurance to undergo genetic testing but if the test has been conducted and the 
information is available, the insurer has the right to request access to that information. However, 
in July 2014, The Office of the Privacy Commissioner of Canada requested that life and health 
insurance companies expand upon a current voluntary moratorium on asking applicants to 
undergo genetic tests and to not inquire about their results at all (Dmitrieva, 2014). The reason 
for the Privacy Commissioner to issue that statement is that it is not clear that the collection and 
the use of genetic test results by insurance companies is demonstrably necessary, effective, 
proportionate, or the least intrusive means of achieving the industry's objectives (Dmitrieva, 
2014). The Privacy Commissioner also realizes that the nature of the genetic test results are 
highly sensitive with low predictive value. Also, it wants to encourage individuals to voluntarily 
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participate in health research without fear that their test results will be used one day against them 
such as their ability to obtain insurance. There is also evidence that restricting insurers from 
access to applicant's genetic test results would not have a significant adverse impact on the 
industry. However, this has led to a huge opposition from the Canadian Life and Health 
Insurance (CLHIA) Association. This is going to be a tough and brutal battle between the 
Privacy Commissioner and the CLHIA, a battle between the public interest and the commercial 
interest.  
 All in all, our study leads us to the answers of the three research questions (page 22). 
First of all, Canadians are very concerned about the privacy of their genetic information. 
However, they do not have a good knowledge about genetic testing or genetic technologies. 
Secondly, They also tend to trust publicly-funded institutions than the privately-funded for 
accessing of our genetic information. Lastly, there is an increasing need for genetic counsellors 
in our health care system and genetics/genomics literacy for physicians and doctors in order to 
assist patients better with their genetic test results. 
 The biggest constraint of this research is the limited diversity in our respondent 
demographics. It is mainly dominated with females, white, aged from 21-29 and majored in 
either Arts and Social Sciences or Communication, Art and Technology. Thus, it does not reflect 
the diversity of British Columbia's population, which is famous for its multicultural ethnicities. 
Time and budget are also the limitations for this research. We only had four months to conduct 
the research, and thus, there might be mistakes and errors in the process of data collection and 
analysis. In all, the social study of genomics science is such a new area that it requires 
tremendous effort to be put into research in order to produce robust but holistic policies and 
bioethics for the study, the use and the application of genetics. For further research, it is a great 
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idea to look into the conflict between the Privacy Commission and the CLHIA to come up with 
solutions or directions that can satisfy both parties and interests. Also, the impacts of genetic 
technologies on women, fertilization and 'designer babies' deserve more attention in research. In 
conclusion, humans have always been trying to conquer the world and control Nature by the 
domination of scientific discoveries. As a result, science is always embedded with human 
ideologies and purposes; and not surprisingly, it is also a form a social control and social 
inequality. Genomics science itself is a wonderful invention that can drive the human race 
forward. It should not be considered a threat to our humanity. Technology is not the one to blame. 
It is social desires that race far ahead of technology.  
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APPENDIX A 
Online Survey Protocol 
Thank you for participating in our survey. Please note that this survey will take approximately 15 
minutes to complete. Our survey aims to explore the perceptions of genetic testing on 
multiple themes among the population in British Columbia. With the popular trend of 
genetic testing today, individuals can learn about their ancestry and genes to prevent any 
potential health risks. However, there are many risks and concerns accompanied with the 
benefits of genetic testing. Could you interpret your own genetic testing result? Are you 
concerned about the privacy of your genetic information? Who gets to control your 
genetic data? This research is hoping to provide information and analyses that will be 
useful towards improving the ethical and procedural guidelines for governing genetic 
information. 
Informed Consent: The University and those conducting this research study subscribe to the 
ethical conduct of research and to the protection at all times of the interests, comfort, and 
safety of participants. This research is being conducted under permission of the Simon 
Fraser Research Ethics Board. The chief concern of the Board is for the health, safety and 
psychological well-being of research participants. Should you wish to obtain information 
about your rights as a participant in research, or about the responsibilities of researchers, 
or if you have any questions, concerns or complaints about the manner in which you were 
treated in this study, please contact the Director, Office of Research Ethics, Dr. Jeff 
Toward by email at jtoward@sfu.ca. 
Title of study: Public perceptions of genetic testing 
Principal Investigator:  Dr. Peter Chow-White (petercw@sfu.ca), Associate Professor of 
Communication 
Co-investigator: Ha Vu Tien Dung (dungh@sfu.ca), BA Candidate of Communication. 
The purpose of the study is to explore the public perceptions on multiple themes  of genetic 
testing in British Columbia in order to contribute to the policymaking process of bringing 
genomics technology from the lab setting into the healthcare system. The procedures to 
be used in this study is to complete an online survey with a set of 32 questions. The 
personal risks to you in taking part in the study are minimal or none. 
The benefits of study to the development of new knowledge: We hope to understand the public 
perceptions on the benefits, the risks and the challenges of the genetic testing that can 
have impacts on any of us. We anticipate that you will have the opportunity to contribute 
to the knowledge base around genetic testing and genetic information. Your output in this 
survey can play a key role in structuring laws and policies to protect our genetic 
information against any misuse or discrimination.  
Our statement of confidentiality is that the confidentiality of your participation will be 
maintained to the extent allowed by the law. The electronic research data will be stored in 
a secure Canada-based server. Other research data and material will be stored in a locked 
file cabinet in the School of Communication. Any descriptive information that might 
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serve to identify participants will not be used in any reports, presentation or publications 
of the study. You will not be named in any reports from this study. Your participation 
will be anonymous and confidential. Names will be kept strictly confidential. You may 
withdraw your participation at any time. If you have any complaint, you can contact our 
Principal Investigator or Co-investigator directly. Or you can also register your complaint 
with the Director of the Office of Research Ethics: Dr. Jeff Toward Director, Office of 
Research Ethics Office of Research Ethics, Simon Fraser University, 8888 University 
Drive, Multi-Tenant Facility Burnaby, BC V5A 1S6, Email: jtoward@sfu.ca, 778-782- 
6593. If you have read and understand the risks and contributions of your participation in 
this study, you can indicate your agreement in the following question. Do you agree to 
participate in the research study described above? 
 
Q1 .     Do you agree to participate in the research study described above? 
 Yes   
 No   
Section A - Background information 
Q2 .     How old are you? 
 18-20   
 21-24   
 25-29   
 30-40   
 40-50   
 50 and above   
Q3 .     Would you classify yourself as: 
 Female   
 Male   
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 Other   
Q4 .     What faculty are you in? 
 Applied Sciences   
 Arts and Social Sciences   
 Beedie School of Business   
 Communication, Art and Technology   
 Education   
 Environment   
 Health Sciences   
 Science   
 Undeclared   
Q5 .     In Canadian politics, which political party would represent your political views best? 
 Conservative Party of Canada   
 New Democratic Party   
 Liberal Party of Canada   
 Bloc Québécois   
 Green Party of Canada   
Q6 .     Would you describe yourself as: 
 Aboriginal People/First Nations   
 Asian   
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 Black/African American   
 Hispanic/Latino   
 White/Caucasian   
 Pacific Islander   
 Other 
Section B - Knowledge and attitudes towards genetic testing and government legislation 
regulating it    
Q7 .     How closely do you follow news reports about developments in science and medicine 
in the last month? 
 Very closely   
 Somewhat closely   
 Not too closely   
 Not closely at all   
 Don't know   
Q8 .     Following is a list of a few topics in genetic testing or genomic technology. How 
much have you heard or read about each of them? 
  
Don'  
know    
Nothing 
Something,  
not much 
A great deal 
Genetic testing, also known as DNA testing, 
allows the genetic diagnosis of 
vulnerabilities to inherited diseases, 
and can also be used to determine a 
child's parentage or in general a 
person's ancestry : 
    
Prenatal screeening, testing for diseases or 
conditions in a fetus or embryo before 
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it is born : 
Designer babies, using research on human 
DNA to produce children with no 
diseases, unusually high intelligence 
or other special attributes : 
    
Biobank, a type of biorepository that stores 
biological samples (usually human) 
for use in research that gives 
researchers access to to data 
representing larger numbers of 
individual people than could be 
analyzed in previously used systems. : 
    
Stem cell research, the biological properties 
of stem cells, with the focus on 
scientific research, and the potential 
use of stem cells in treating disease. : 
    
 
Q9 .     The next few questions will be about genetic testing. Have you ever heard of any 
genetic testing services/companies? 
 Yes   
 No   
 
 
Q10 .     If your answer was Yes in the previous question, could you please specify which 
genetic testing services/companies you've heard of? Otherwise, please leave it blank. 
Thank you. 
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Q11 .     Have you, or has anyone in your immediate family, ever had a genetic disease? 
 Yes   
 No   
 Don't know   
Q12 .     Have you, or has anyone in your immediate family, ever had a genetic test? 
 Yes   
 No   
 Don't know   
Q13 .     Would you consider having your genes tested in the future? 
 Yes   
 No   
 Don't know   
Q14 .     What are the factors that can lead you to do genetic testing? 
 To understand about my genetic make-up 
 To see if a specific disease runs in my family or is in my DNA 
 To participate in a study for the public good on human genetics or human genome 
 Other 
Q15 .     Please specify if your answer was "Other" in the previous question. Otherwise, 
please leave it blank. 
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Q16 .     What are the factors that can discourage you from doing genetic testing? 
 The doubt for the usefulness of the test result 
 The cost of the genetic testing service 
 The concerns about genetic information 
 The reliability of the result 
 The potential return of unwanted information 
Q17 .     What are the actions you are going to take after having your gene tested? 
 Increase my control over my health 
 Stimulate discussion about personal health within families 
 Influence my future health care decisions 
 Consult a physician 
 Modify my lifestyle if risk genes diagnosed 
 Do nothing 
 
Q18 .     As far as you know, does the government regulate genetic testing, or not? 
 Yes   
 No   
 Don't know   
Q19 .     Do you think the government SHOULD regulate genetic testing, or not? 
 Yes   
 No   
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 Don't know   
Section C  - The impact of genetic technologies on women 
Q20 .     As far as you know, is it scientifically possible today to use genetic testing during 
PREGNANCY to find out whether the baby will develop a disease such as sickle cell 
disease or cystic fibrosis? 
 Yes   
 No   
 Don't know   
Q21 .     As far as you know, is it scientifically possible today to change a baby’s genetic 
make-up before it is born so it is smarter, stronger, or better looking? 
 Yes   
 No   
 Don't know   
 
Q22 .     Have you or has anyone you know well ever thought to become pregnant by using 
the process of in vitro fertilization? (In vitro fertilization is the process where eggs 
are removed from a woman’s ovaries, fertilized in the laboratory with sperm, then 
implanted in a woman's womb, where they grow and are born like other babies.) 
 Yes   
 No   
 Don't know   
Q23 .     (READ IF FEMALE) On May 14, 2013, Angelina Jolie was diagnosed with a fatal 
gene, BRCA1, which sharply increased her risk of developing breast cancer and 
ovarian cancer. As a result, she decided to do a double mastectomy (the surgical 
removal of one or both breasts, partially or completely, to eliminate breast cancer 
tissue). If your genetic testing showed that you were carrying the BRCA1 or BRCA2 
mutations which may cause you breast cancer, would you conduct (double) 
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mastectomy operations as Angelina Jolie did to prevent the risk of having breast 
cancer? 
 Yes   
 No   
 Don't know   
Q24 .     As far as you know, does the government regulate mastectomy, or not? 
 Yes   
 No   
 Don't know   
Q25 .     Do you think the government should regulate mastectomy, or not? 
 Yes   
 No   
 Don't know   
Section D - Healthcare system implications 
Q26 .     Do you consider the genetic test result as a medical diagnosis? 
 Yes   
 No   
 Don't know   
Q27 .     Who would you ask to interpret the genetic test result for you? 
 I have enough knowledge about genetics to understand the results   
 I would ask the genetic testing services to interpret the results   
 
54 PUBLIC PERCEPTIONS OF GENETIC TESTING 
 I would ask the physicians to interpret the results   
 I would not do anything with the results   
Q28 .     Should the physician interpret your genetic test results for you? 
 Yes, because physicians have enough knowledge to interpret the results   
 Yes, because physicians have a professional obligation to help individuals understand the 
results   
 No   
Section E - Privacy concerns about genetic information such as access, control and trust 
Q29 .     To what extent would you agree or disagree with the ethical and legal statements 
about genetic information below? 
  
Strongly  
disagree 
Disagree Neutral Agree Strongly agree 
We should be concerned about the privacy of 
our genetic information :      
We should allow our genetic information to 
be stored in biobanks for research 
purposes : 
     
We should allow researchers to share our 
personal information or personal 
identity with our genetic samples with 
the public : 
     
Laws/policies/rules governing the protection 
of our genetic information should be 
stricter than for other forms of 
personal information : 
     
Q30 .     How much do you trust each of the following to have access to your genetic test 
results? 
  None A little Some A lot 
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Your doctor/physician :     
Your family members :     
Researchers funded by private sector or by 
industry :     
Researchers from public hospitals or 
universities :     
Law enforcement :     
Your health insurer :     
Your employer :     
 
Section F - Ethical implications of genetic testing 
Q31 .     To what extent would you support or oppose the uses of genetic testing under each 
of these scenarios? 
  
Strongly  
oppose 
Oppose Neutral Support 
Strongly  
support 
Researchers, to find new ways to diagnose, 
prevent or treat diseases :      
Doctors/physicians, to identify a person's risk 
of having a bad reaction to a particular 
medicine : 
     
Doctors/physicians, to identify a person's risk 
of having a child with a serious 
genetic disease : 
     
Parents, to design their unborn babies with all 
desirable traits such as high 
intelligence or strength : 
     
Doctors/physicians, to identify a person's risk 
of a disease where no treatment or 
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medication exist : 
Employers, to make decisions about hiring or 
promotion :      
Health insurance companies, to determine 
whom to insure or how much to 
charge : 
     
 
 
Q32 .     On a scale of 1 to 5 (1=Completely unethical, 5=Completely Ethical), how would 
you feel about each situation below? 
  1 2 3 4 5 
Employers request genetic profiles from 
prospective employees before 
deciding to hire them or not : 
     
Health insurance companies require genetic 
information before deciding on the 
cost of health coverage : 
     
Researchers use our genetic information in 
their research study without our 
informed consent : 
     
Patent law can be applied to human genetic 
material, which means we can buy a 
patent for our genetic material : 
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APPENDIX B 
Additional data analysis 
 
Table 1: Cross tabulation between Political View and Should government regulate genetic testing? 
 
Political View * Should the government regulate genetic testing? Crosstabulation 
 
Should the government regulate genetic 
testing? 
Total Don't know No Yes 
Political View Conservative Part 
of Canada 
Count 3 1 7 11 
% within Political 
View 
27.3% 9.1% 63.6% 100.0% 
% within Should 
the government 
regulate genetic 
testing? 
11.5% 6.7% 11.9% 11.0% 
% of Total 3.0% 1.0% 7.0% 11.0% 
Don't know Count 10 9 15 34 
% within Political 
View 
29.4% 26.5% 44.1% 100.0% 
% within Should 
the government 
regulate genetic 
testing? 
38.5% 60.0% 25.4% 34.0% 
% of Total 10.0% 9.0% 15.0% 34.0% 
Green Party of 
Canada 
Count 2 1 3 6 
% within Political 
View 
33.3% 16.7% 50.0% 100.0% 
% within Should 
the government 
regulate genetic 
testing? 
7.7% 6.7% 5.1% 6.0% 
% of Total 2.0% 1.0% 3.0% 6.0% 
Liberal Party of 
Canada 
Count 3 2 9 14 
% within Political 
View 
21.4% 14.3% 64.3% 100.0% 
% within Should 
the government 
regulate genetic 
testing? 
11.5% 13.3% 15.3% 14.0% 
% of Total 3.0% 2.0% 9.0% 14.0% 
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New Democratic 
Party 
Count 8 2 25 35 
% within Political 
View 
22.9% 5.7% 71.4% 100.0% 
% within Should 
the government 
regulate genetic 
testing? 
30.8% 13.3% 42.4% 35.0% 
% of Total 8.0% 2.0% 25.0% 35.0% 
Total Count 26 15 59 100 
% within Political 
View 
26.0% 15.0% 59.0% 100.0% 
% within Should 
the government 
regulate genetic 
testing? 
100.0% 100.0% 100.0% 100.0% 
% of Total 26.0% 15.0% 59.0% 100.0% 
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Table 2: Cross tabulation between Political View and Should the government regulate genetic technologies?  
 
Political View * Should the government regulate genetic technologies?  Crosstabulation 
 
Should the government regulate genetic 
technologies? 
Total Don't know No Yes 
Political View Conservative Part 
of Canada 
Count 4 2 5 11 
% within Political 
View 
36.4% 18.2% 45.5% 100.0% 
% within Should 
the government 
regulate genetic 
technologies? 
12.9% 14.3% 9.1% 11.0% 
% of Total 4.0% 2.0% 5.0% 11.0% 
Don't know Count 13 6 15 34 
% within Political 
View 
38.2% 17.6% 44.1% 100.0% 
% within Should 
the government 
regulate genetic 
technologies? 
41.9% 42.9% 27.3% 34.0% 
% of Total 13.0% 6.0% 15.0% 34.0% 
Green Party of 
Canada 
Count 2 1 3 6 
% within Political 
View 
33.3% 16.7% 50.0% 100.0% 
% within Should 
the government 
regulate genetic 
technologies? 
6.5% 7.1% 5.5% 6.0% 
% of Total 2.0% 1.0% 3.0% 6.0% 
Liberal Party of 
Canada 
Count 5 2 7 14 
% within Political 
View 
35.7% 14.3% 50.0% 100.0% 
% within Should 
the government 
regulate genetic 
technologies? 
16.1% 14.3% 12.7% 14.0% 
% of Total 5.0% 2.0% 7.0% 14.0% 
New Democratic Count 7 3 25 35 
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Party % within Political 
View 
20.0% 8.6% 71.4% 100.0% 
% within Should 
the government 
regulate genetic 
technologies? 
22.6% 21.4% 45.5% 35.0% 
% of Total 7.0% 3.0% 25.0% 35.0% 
Total Count 31 14 55 100 
% within Political 
View 
31.0% 14.0% 55.0% 100.0% 
% within Should 
the government 
regulate genetic 
technologies? 
100.0% 100.0% 100.0% 100.0% 
% of Total 31.0% 14.0% 55.0% 100.0% 
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Table 3: Cross tabulation between Political View and Should genetic law be stricter than other forms of personal 
information? 
 
Political View * Genetic law stricter Crosstabulation 
 
Genetic law stricter 
Total Agree Disagree Neutral 
Strongly 
agree 
Strongly 
disagree 
Political View Conservative Part 
of Canada 
Count 2 0 4 5 0 11 
% within Political 
View 
18.2% 0.0% 36.4% 45.5% 0.0% 100.0% 
% within Genetic 
law stricter 
5.7% 0.0% 12.9% 20.8% 0.0% 11.0% 
% of Total 2.0% 0.0% 4.0% 5.0% 0.0% 11.0% 
Don't know Count 12 3 13 6 0 34 
% within Political 
View 
35.3% 8.8% 38.2% 17.6% 0.0% 100.0% 
% within Genetic 
law stricter 
34.3% 37.5% 41.9% 25.0% 0.0% 34.0% 
% of Total 12.0% 3.0% 13.0% 6.0% 0.0% 34.0% 
Green Party of 
Canada 
Count 3 1 1 1 0 6 
% within Political 
View 
50.0% 16.7% 16.7% 16.7% 0.0% 100.0% 
% within Genetic 
law stricter 
8.6% 12.5% 3.2% 4.2% 0.0% 6.0% 
% of Total 3.0% 1.0% 1.0% 1.0% 0.0% 6.0% 
Liberal Party of 
Canada 
Count 5 1 3 4 1 14 
% within Political 
View 
35.7% 7.1% 21.4% 28.6% 7.1% 100.0% 
% within Genetic 
law stricter 
14.3% 12.5% 9.7% 16.7% 50.0% 14.0% 
% of Total 5.0% 1.0% 3.0% 4.0% 1.0% 14.0% 
New Democratic 
Party 
Count 13 3 10 8 1 35 
% within Political 
View 
37.1% 8.6% 28.6% 22.9% 2.9% 100.0% 
% within Genetic 
law stricter 
37.1% 37.5% 32.3% 33.3% 50.0% 35.0% 
% of Total 13.0% 3.0% 10.0% 8.0% 1.0% 35.0% 
Total Count 35 8 31 24 2 100 
% within Political 
View 
35.0% 8.0% 31.0% 24.0% 2.0% 100.0% 
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% within Genetic 
law stricter 
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 
% of Total 35.0% 8.0% 31.0% 24.0% 2.0% 100.0% 
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Table 4: Cross tabulation between the awareness of Angelina event and the opinion on double mastectomy 
 
Angelina Jolie * Double Masectomy Crosstabulation 
 
Double Masectomy 
Total Don't know No Yes 
Angelina 
Jolie 
Don't know Count 1 0 0 1 
% within 
Angelina Jolie 
100.0% 0.0% 0.0% 100.0% 
% within Double 
Masectomy 
2.4% 0.0% 0.0% 1.0% 
% of Total 1.0% 0.0% 0.0% 1.0% 
No Count 9 7 6 22 
% within 
Angelina Jolie 
40.9% 31.8% 27.3% 100.0% 
% within Double 
Masectomy 
22.0% 35.0% 15.4% 22.0% 
% of Total 9.0% 7.0% 6.0% 22.0% 
Yes Count 31 13 33 77 
% within 
Angelina Jolie 
40.3% 16.9% 42.9% 100.0% 
% within Double 
Masectomy 
75.6% 65.0% 84.6% 77.0% 
% of Total 31.0% 13.0% 33.0% 77.0% 
Total Count 41 20 39 100 
% within 
Angelina Jolie 
41.0% 20.0% 39.0% 100.0% 
% within Double 
Masectomy 
100.0% 100.0% 100.0% 100.0% 
% of Total 41.0% 20.0% 39.0% 100.0% 
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Table 5: Cross tabulation between age and the level of concern about the genetic information concern 
 
Age * Genetic information privacy concern Crosstabulation 
 
Genetic information privacy concern 
Total Agree Disagree Neutral 
Strongly 
agree 
Strongly 
disagree 
Age 18-20 Count 3 1 3 3 1 11 
% within Age 27.3% 9.1% 27.3% 27.3% 9.1% 100.0% 
% within Genetic 
information 
privacy concern 
8.3% 33.3% 20.0% 6.8% 50.0% 11.0% 
% of Total 3.0% 1.0% 3.0% 3.0% 1.0% 11.0% 
21-24 Count 18 0 5 16 1 40 
% within Age 45.0% 0.0% 12.5% 40.0% 2.5% 100.0% 
% within Genetic 
information 
privacy concern 
50.0% 0.0% 33.3% 36.4% 50.0% 40.0% 
% of Total 18.0% 0.0% 5.0% 16.0% 1.0% 40.0% 
25-29 Count 7 2 3 10 0 22 
% within Age 31.8% 9.1% 13.6% 45.5% 0.0% 100.0% 
% within Genetic 
information 
privacy concern 
19.4% 66.7% 20.0% 22.7% 0.0% 22.0% 
% of Total 7.0% 2.0% 3.0% 10.0% 0.0% 22.0% 
30-40 Count 4 0 3 8 0 15 
% within Age 26.7% 0.0% 20.0% 53.3% 0.0% 100.0% 
% within Genetic 
information 
privacy concern 
11.1% 0.0% 20.0% 18.2% 0.0% 15.0% 
% of Total 4.0% 0.0% 3.0% 8.0% 0.0% 15.0% 
40-50 Count 2 0 1 1 0 4 
% within Age 50.0% 0.0% 25.0% 25.0% 0.0% 100.0% 
% within Genetic 
information 
privacy concern 
5.6% 0.0% 6.7% 2.3% 0.0% 4.0% 
% of Total 2.0% 0.0% 1.0% 1.0% 0.0% 4.0% 
50 and above Count 2 0 0 6 0 8 
% within Age 25.0% 0.0% 0.0% 75.0% 0.0% 100.0% 
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% within Genetic 
information 
privacy concern 
5.6% 0.0% 0.0% 13.6% 0.0% 8.0% 
% of Total 2.0% 0.0% 0.0% 6.0% 0.0% 8.0% 
Total Count 36 3 15 44 2 100 
% within Age 36.0% 3.0% 15.0% 44.0% 2.0% 100.0% 
% within Genetic 
information 
privacy concern 
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 
% of Total 36.0% 3.0% 15.0% 44.0% 2.0% 100.0% 
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Table 6: Cross tabulation between Gender and the opinions on designing babies 
 
 
Gender * Design babies Crosstabulation 
 
Design babies 
Total Neutral Oppose 
Strongly 
oppose 
Strongly 
support Support 
Gender Female Count 7 14 33 1 7 62 
% within Gender 11.3% 22.6% 53.2% 1.6% 11.3% 100.0% 
% within Design 
babies 
43.8% 58.3% 70.2% 33.3% 70.0% 62.0% 
Male Count 9 10 13 2 3 37 
% within Gender 24.3% 27.0% 35.1% 5.4% 8.1% 100.0% 
% within Design 
babies 
56.3% 41.7% 27.7% 66.7% 30.0% 37.0% 
Other Count 0 0 1 0 0 1 
% within Gender 0.0% 0.0% 100.0% 0.0% 0.0% 100.0% 
% within Design 
babies 
0.0% 0.0% 2.1% 0.0% 0.0% 1.0% 
Total Count 16 24 47 3 10 100 
% within Gender 16.0% 24.0% 47.0% 3.0% 10.0% 100.0% 
% within Design 
babies 
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 
 
 
 
 
 
 
 
 
 
